Rheingold Susan R, Brown Valerie I, Fang Junjie, Kim Jenny M, Grupp Stephan A
Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Immunol Res. 2003;27(2-3):309-30. doi: 10.1385/IR:27:2-3:309.
A primary focus of signal transduction in B cells, from the pre-B cell to the mature B cell, is the B cell receptor complex. Here we describe work demonstrating the importance of signaling via the pre-B cell receptor complex (pre-BCR) to the pre-B cell transition, the central checkpoint in B-cell development. We have shown tht pre-BCR complex components Igalpha and Igbeta are critical to allowing the pre-B cell to move through this transition, but may not be required for allelic exclusion. Pre-BCR expression also directly affects the response of leukemic cells to steroid treatment, suggesting that signals initiated by the pre-BCR complex may present therapeutic targets in acute leukemia. Additionally, interleukin-7 may also modulate the response of leukemic cells arising from early B-cell stages to treatment. This observation has lead directly to proposals to test drugs which may antagonize early B-cell growth signals, such as rapamycin, in acute lymphoid leukemia.
从前B细胞到成熟B细胞,B细胞中信号转导的一个主要焦点是B细胞受体复合物。在此,我们描述了一些工作,这些工作证明了通过前B细胞受体复合物(pre-BCR)发出信号对前B细胞转变的重要性,前B细胞转变是B细胞发育的核心检查点。我们已经表明,前BCR复合物成分Igalpha和Igbeta对于前B细胞通过这一转变至关重要,但等位基因排斥可能不需要它们。前BCR的表达也直接影响白血病细胞对类固醇治疗的反应,这表明前BCR复合物引发的信号可能是急性白血病的治疗靶点。此外,白细胞介素-7也可能调节早期B细胞阶段产生的白血病细胞对治疗的反应。这一观察结果直接导致了在急性淋巴细胞白血病中测试可能拮抗早期B细胞生长信号的药物(如雷帕霉素)的提议。